Advertisement

Picture [iito] Made Without Love 650x80px
Organisation › Details

ExeVir Bio B.V.

ExeVir Bio is harnessing its VHH technology platform to generate robust antiviral therapies providing broad protection against viral infections, including coronaviruses. It is a spin out from VIB, the world class Belgium-based life sciences research institute, based on the work of Professor Drs Xavier Saelens and Nico Callewaert from VIB in collaboration with: Laboratory of Jason McLellan – University of Texas at Austin; Laboratory of Barney Graham – NIAID (Vaccine Research Center); Laboratory of Johan Neyts – KU Leuven (Rega Institute). ExeVir Bio is led by a team of experts that combines international biotech and pharma experience with a successful track record of developing and bringing products to market. It is backed by blue chip investors led by Fund+, VIB, UCB Ventures, FPIM, V-Bio and Several Belgian Family Offices. *

 

Period Start 2020-07-28 existent
  Predecessor VIB (Flanders Interuniversity Institute for Biotechnology / Vlaams Instituut voor Biotechnologie)
Products Industry VHH antibody technology (Llama-derived antibody technology)
  Industry 2 virostatic agent
Persons Person Mummenbrauer, Torsten (ExeVir Bio 202006– CEO before Velvio Gmbh + Hookipa + MorphoSys + GSK Vaccines)
  Person 2 Monteyne, Philippe (Fund+ 201610 Partner)
     
Region Region Zwijnaarde
  Country Belgium
  Street 120 Rijvisschersstraat
  City 9052 Zwijnaarde
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: ExeVir Bio B.V.. (7/28/20). "Press Release: ExeVir Bio to Accelerate Development of New Treatment Conferring Broad Protection Against COVID-19. EUR23M Series A Financing to Advance Lead Novel Llama-derived Antibody into Clinical Trials". Leuven.
     
   
Record changed: 2021-03-16

Advertisement

Picture [iito] Made Without Love 650x80px

More documents for ExeVir Bio B.V.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80




» top